Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS

Adi Vaknin-Dembinsky, Steven Brass, Roopali Gandhi, Howard L. Weiner

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

IL-15 is a pro-inflammatory cytokine whose three-dimensional structure is similar to that of IL-2. IL-2 and IL-15 have similar as well as distinct biological functions. An active form of IL-15 that is membrane bound has also been described. Furthermore, IL-15 is known to play a role in autoimmune diseases. We thus investigated the expression of membrane bound IL-15 on monocytes (CD14+ cells) and studied its effect on T cell activation in MS patients. We found that unstimulated CD14+ cells from relapsing remitting MS patients had increased membrane bound IL-15. Those with high surface levels of IL-15 on monocytes were in the early stages of the disease. In addition, we found that T cells of MS patients had enhanced responsiveness to IL-15 and there was increased expression of IL-15 receptor on CD4+ T cells. Thus, IL-15 may be an important cytokine that drives Th1 responses early in the course of the disease and could serve as a target for immunotherapy and as an early marker in the immunologic staging of MS.

Original languageEnglish (US)
Pages (from-to)135-139
Number of pages5
JournalJournal of Neuroimmunology
Volume195
Issue number1-2
DOIs
StatePublished - Mar 2008
Externally publishedYes

Fingerprint

Interleukin-15
Monocytes
Membranes
T-Lymphocytes
Interleukin-2
Interleukin-15 Receptors
Cytokines
Immunotherapy
Autoimmune Diseases
Biomarkers

Keywords

  • IL-15
  • Monocytes
  • Multiple sclerosis

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS. / Vaknin-Dembinsky, Adi; Brass, Steven; Gandhi, Roopali; Weiner, Howard L.

In: Journal of Neuroimmunology, Vol. 195, No. 1-2, 03.2008, p. 135-139.

Research output: Contribution to journalArticle

Vaknin-Dembinsky, A, Brass, S, Gandhi, R & Weiner, HL 2008, 'Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS', Journal of Neuroimmunology, vol. 195, no. 1-2, pp. 135-139. https://doi.org/10.1016/j.jneuroim.2008.01.016
Vaknin-Dembinsky, Adi ; Brass, Steven ; Gandhi, Roopali ; Weiner, Howard L. / Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS. In: Journal of Neuroimmunology. 2008 ; Vol. 195, No. 1-2. pp. 135-139.
@article{be451502320c47c39ee85769f04ed8cd,
title = "Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS",
abstract = "IL-15 is a pro-inflammatory cytokine whose three-dimensional structure is similar to that of IL-2. IL-2 and IL-15 have similar as well as distinct biological functions. An active form of IL-15 that is membrane bound has also been described. Furthermore, IL-15 is known to play a role in autoimmune diseases. We thus investigated the expression of membrane bound IL-15 on monocytes (CD14+ cells) and studied its effect on T cell activation in MS patients. We found that unstimulated CD14+ cells from relapsing remitting MS patients had increased membrane bound IL-15. Those with high surface levels of IL-15 on monocytes were in the early stages of the disease. In addition, we found that T cells of MS patients had enhanced responsiveness to IL-15 and there was increased expression of IL-15 receptor on CD4+ T cells. Thus, IL-15 may be an important cytokine that drives Th1 responses early in the course of the disease and could serve as a target for immunotherapy and as an early marker in the immunologic staging of MS.",
keywords = "IL-15, Monocytes, Multiple sclerosis",
author = "Adi Vaknin-Dembinsky and Steven Brass and Roopali Gandhi and Weiner, {Howard L.}",
year = "2008",
month = "3",
doi = "10.1016/j.jneuroim.2008.01.016",
language = "English (US)",
volume = "195",
pages = "135--139",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS

AU - Vaknin-Dembinsky, Adi

AU - Brass, Steven

AU - Gandhi, Roopali

AU - Weiner, Howard L.

PY - 2008/3

Y1 - 2008/3

N2 - IL-15 is a pro-inflammatory cytokine whose three-dimensional structure is similar to that of IL-2. IL-2 and IL-15 have similar as well as distinct biological functions. An active form of IL-15 that is membrane bound has also been described. Furthermore, IL-15 is known to play a role in autoimmune diseases. We thus investigated the expression of membrane bound IL-15 on monocytes (CD14+ cells) and studied its effect on T cell activation in MS patients. We found that unstimulated CD14+ cells from relapsing remitting MS patients had increased membrane bound IL-15. Those with high surface levels of IL-15 on monocytes were in the early stages of the disease. In addition, we found that T cells of MS patients had enhanced responsiveness to IL-15 and there was increased expression of IL-15 receptor on CD4+ T cells. Thus, IL-15 may be an important cytokine that drives Th1 responses early in the course of the disease and could serve as a target for immunotherapy and as an early marker in the immunologic staging of MS.

AB - IL-15 is a pro-inflammatory cytokine whose three-dimensional structure is similar to that of IL-2. IL-2 and IL-15 have similar as well as distinct biological functions. An active form of IL-15 that is membrane bound has also been described. Furthermore, IL-15 is known to play a role in autoimmune diseases. We thus investigated the expression of membrane bound IL-15 on monocytes (CD14+ cells) and studied its effect on T cell activation in MS patients. We found that unstimulated CD14+ cells from relapsing remitting MS patients had increased membrane bound IL-15. Those with high surface levels of IL-15 on monocytes were in the early stages of the disease. In addition, we found that T cells of MS patients had enhanced responsiveness to IL-15 and there was increased expression of IL-15 receptor on CD4+ T cells. Thus, IL-15 may be an important cytokine that drives Th1 responses early in the course of the disease and could serve as a target for immunotherapy and as an early marker in the immunologic staging of MS.

KW - IL-15

KW - Monocytes

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=41949095273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949095273&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2008.01.016

DO - 10.1016/j.jneuroim.2008.01.016

M3 - Article

C2 - 18378324

AN - SCOPUS:41949095273

VL - 195

SP - 135

EP - 139

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -